Deciphera Pharmaceuticals Inc 's ability to collect accounts receivable sequentially worsen to 6.06, indicating more challenging environment then in the fourth quarter 2023, but still, it is a far cry from any concerns. Deciphera Pharmaceuticals Inc 's Accounts Receivable average collection period in the Mar 31 2024 quarter, has increased to 60 days, from 59 days, in the Dec 31 2023 quarter.

If we take a look into Healthcare sector 320 other companies have achieved higher receivables turnover ratio. While receivables turnover ratio total ranking has improved thus far to 2446, from overall ranking in the fourth quarter 2023 at 2765.

What is Receivable Turnover Ratio?
What is Deciphera Pharmaceuticals Inc Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

DCPH Receivables Turnover Ratio	(Mar 31 2024) I. Quarter	(Dec 31 2023) IV. Quarter	(Sep 30 2023) III. Quarter	(Jun 30 2023) II. Quarter	(Mar 31 2023) I. Quarter
Y / Y Receivable Change	45.66 %	42.46 %	18.35 %	-10.25 %	-3.08 %
Y / Y Revenue Change	34.55 %	32.88 %	20.4 %	17.88 %	14.45 %
Receivable Turnover Ratio (TTM)	6.06	6.21	6.33	6.31	5.88
DCPH's Total Ranking	# 2446	# 2765	# 2403	# 2448	# 2658
Accounts Receivable average collection period days	60	59	58	58	62
Seq. Receivable Change	2.29 %	15.98 %	18.75 %	3.39 %	0.04 %
Seq. Revenue Change	-6.82 %	11.5 %	13.08 %	14.53 %	-7.98 %

Receivable Turnover Company Ranking
Within:	No.
Major Pharmaceutical Preparations Industry	# 95
Healthcare Sector	# 321
Overall Market	# 2446

Receivable Turnover Ratio Statistics
High	Average	Low
6.33	4.18	-1.51
(Sep 30 2023)		(Sep 30 2020)

DCPH Company Profile • Back to DCPH Efficiency Comparisons • Compare DCPH Receivables Turnover Ratio to its Competitors

Financial Statements
Deciphera Pharmaceuticals Inc 's Accounts Receivable	$ 33 Millions	Visit DCPH's Balance sheet
Deciphera Pharmaceuticals Inc 's Sales TTM	$ 175 Millions	Visit DCPH's Income Statement
Sources of DCPH's Revenues		Visit DCPH's Sales by Geography

Other Accounts Receivable Turnover Ratios
Major Pharmaceutical Preparations Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
DCPH's Receivable Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
DCPH's Growth Rates	DCPH's Roa	DCPH's Inventory Turnover Ratio	DCPH's Dividend Comparisons
DCPH's Profitability Ratios	DCPH's Roi	DCPH's Asset Turnover Ratio	DCPH's Dividend Growth
DCPH's Valuation Ratios	DCPH's Roe	DCPH's Financial Strength Ratios	DCPH's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Mar 31 2024, within Healthcare Sector	Receivable Turnover Ratio	Revenues for 12 Months ending Mar 31 2024	Receivable at quarter ending Mar 31 2024
China Health Industries Holdings Inc	14.34	$ 0.061 Millions	$ 0.004 Millions
Icu Medical Inc	14.31	$ 2,256.721 Millions	$ 157.694 Millions
Ensysce Biosciences Inc	14.23	$ 2.101 Millions	$ 0.148 Millions
Chemed Corporation	14.18	$ 2,293.493 Millions	$ 161.797 Millions
Precipio inc	13.83	$ 15.812 Millions	$ 1.144 Millions
Innovative Eyewear Inc	13.76	$ 1.391 Millions	$ 0.101 Millions
Rosecliff Acquisition Corp I	13.76	$ 19.304 Millions	$ 1.403 Millions
Utah Medical Products Inc	13.74	$ 48.343 Millions	$ 3.518 Millions
Patterson Companies Inc	13.60	$ 6,568.242 Millions	$ 482.794 Millions
Gyre Therapeutics Inc	13.30	$ 115.691 Millions	$ 8.696 Millions
Eyepoint Inc	13.12	$ 50.019 Millions	$ 3.814 Millions
Amylyx Pharmaceuticals Inc	12.92	$ 398.001 Millions	$ 30.807 Millions
Nutriband Inc	12.87	$ 2.017 Millions	$ 0.157 Millions
Inovio Pharmaceuticals Inc	12.74	$ 8.143 Millions	$ 0.639 Millions
Traws Pharma inc	12.73	$ 0.226 Millions	$ 0.018 Millions
Petvivo Holdings Inc	12.57	$ 0.969 Millions	$ 0.077 Millions
International Stem Cell Corporation	12.47	$ 7.832 Millions	$ 0.628 Millions
Exact Sciences Corporation	12.40	$ 2,547.946 Millions	$ 205.482 Millions
Caribou Biosciences Inc	12.35	$ 33.404 Millions	$ 2.704 Millions
Corcept Therapeutics Inc	12.33	$ 523.529 Millions	$ 42.455 Millions
Teladoc Health Inc	12.29	$ 2,619.302 Millions	$ 213.191 Millions
Lifeloc Technologies Inc	12.26	$ 9.318 Millions	$ 0.760 Millions
Lftd Partners Inc	12.01	$ 49.815 Millions	$ 4.149 Millions
Xoma Royalty Corporation	11.91	$ 5.811 Millions	$ 0.488 Millions
Siga Technologies Inc	11.78	$ 157.024 Millions	$ 13.334 Millions
Nrc Health	11.65	$ 147.420 Millions	$ 12.653 Millions
Valion Bio Inc	11.57	$ 1.134 Millions	$ 0.098 Millions
Surmodics Inc	11.57	$ 142.963 Millions	$ 12.360 Millions
Sunshine Biopharma Inc	11.35	$ 26.740 Millions	$ 2.356 Millions
Integrated Biopharma Inc	11.20	$ 47.983 Millions	$ 4.284 Millions

Date modified: 2026-08-29T17:38:25+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.